Actively Recruiting
COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)
Led by Odense University Hospital · Updated on 2023-12-06
100
Participants Needed
1
Research Sites
582 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients with loco-regional NSCLC planned for curative treatment with chemoradiotherapy will be invited to participate in a prospective study; besides routine treatment, the patients will be followed with an ECG and cardiac MR for at least two years after radiotherapy treatment.
CONDITIONS
Official Title
COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age �38 18 Years
- Inoperable and histologically/cytologically verified NSCLC
- Planned treatment with curative intent
- Capable of completing study procedures ECG and Cardiac MR
- Able of giving written and informed consent before study procedures are initiated
You will not qualify if you...
- Vulnerable patients
- Patients with operable devices as pacemaker/ICD and cochlear implant or other conditions where MR scan is contraindicated
- Claustrophobia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Odense University Hospital
Odense C, Denmark, 5000
Actively Recruiting
Research Team
A
Agon AO Olloni, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here